Lataa...
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors
Background/Aim: Nelfinavir is a human immunodeficiency virus protease inhibitor that is currently being repositioned as an anticancer drug. Chloroquine, an anti-malarial lysosomotropic drug, inhibits autophagy. It has been reported that the combination of nelfinavir and chloroquine significantly enh...
Tallennettuna:
| Julkaisussa: | In Vivo |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
International Institute of Anticancer Research
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880743/ https://ncbi.nlm.nih.gov/pubmed/33402459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12241 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|